Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugo, T.
Right arrow Articles by Matsuda, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugo, T.
Right arrow Articles by Matsuda, M.
Related Collections
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 94 No. 11 (December 1), 1999: pp. 3806-3813

Fibrinogen Niigata With Impaired Fibrin Assembly: An Inherited Dysfibrinogen With a Bbeta Asn-160 to Ser Substitution Associated With Extra Glycosylation at Bbeta Asn-158

Teruko Sugo, Chizuko Nakamikawa, Hiroshi Takano, Jun Mimuro, Shu-ichi Yamaguchi, Michael W. Mosesson, David A. Meh, James P. DiOrio, Noriko Takahashi, Hoyu Takahashi, Koichi Nagai, and Michio Matsuda

From the Institute of Hematology, Jichi Medical School, Tochigi, Japan; Sinai Samaritan Medical Center, University of Wisconsin Medical School, Milwaukee Clinical Campus, Milwaukee, WI; Baxter Healthcare, Round Lake, IL; GlycoLab, Nakano Vinegar Co, Handa, Aichi, Japan; Katahigashi-Keyaki Hospital, Katahigashimura, Niigata, Japan; and Niigata Prefectural Central Hospital, Joetsu, Niigata, Japan.

A novel Bbeta Asn-160 (TAA) to Ser (TGA) substitution has been identified in fibrinogen Niigata derived from a 64-year-old asymptomatic woman, who is heterozygotic for this abnormality. The mutation creates an Asn-X-Ser-type glycosylation sequence, and a partially sialylated biantennary oligosaccharide was linked to the Bbeta Asn-158 residue. The functional abnormality was attributed to delayed lateral association of normally formed double-stranded protofibrils based on normal cross-linking of fibrin gamma -chains and tissue-type plasminogen activator-catalyzed plasmin generation by polymerizing fibrin monomers. Enzymatic removal of all the N-linked oligosaccharides from fibrinogen Niigata accelerated fibrin monomer polymerization that reached the level of untreated normal fibrin monomers, but the thrombin time was prolonged from 18.2 seconds to 113 seconds (normal: 11.2 seconds to 8.9 seconds). By scanning electron micrographic analysis, Niigata fibrin fibers were found to be more curvilinear than normal fibrin fibers. After deglycosylation, Niigata fibers became straight being similar to untreated normal fibrin fibers, whereas normal deglycosylated fibrin appeared to be less-branched than untreated normal or deglycosylated Niigata fibrin. Although normal and Niigata fibrins were similar to each other in permeation and compaction studies, deglycosylated normal and Niigata fibrins had much higher permeability and compaction values, indicating that deglycosylation had brought about the formation of more porous networks. The enzymatic deglycosylation necessitates an Asn to Asp change at position Bbeta -158 that is responsible for reducing the fiber thickness because of either local repulsive forces or steric hindrance in the coiled-coil region.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. A. Amelot, M. Tagzirt, G. Ducouret, R. L. Kuen, and B. F. Le Bonniec
Platelet Factor 4 (CXCL4) Seals Blood Clots by Altering the Structure of Fibrin
J. Biol. Chem., January 5, 2007; 282(1): 710 - 720.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Hamano, J. Mimuro, M. Aoshima, T. Itoh, N. Kitamura, S. Nishinarita, K. Takano, A. Ishiwata, Y. Kashiwakura, K. Niwa, et al.
Thrombophilic dysfibrinogen Tokyo V with the amino acid substitution of {gamma} Ala327Thr: formation of fragile but fibrinolysis-resistant fibrin clots and its relevance to arterial thromboembolism
Blood, April 15, 2004; 103(8): 3045 - 3050.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. C. Lounes, J. B. Lefkowitz, A. H. Henschen-Edman, A. I. Coates, R. R. Hantgan, and S. T. Lord
The impaired polymerization of fibrinogen Longmont (B{beta}166Arg{right-arrow}Cys) is not improved by removal of disulfide-linked dimers from a mixture of dimers and cysteine-linked monomers
Blood, August 1, 2001; 98(3): 661 - 666.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Sugo, C. Nakamikawa, N. Yoshida, K. Niwa, M. Sameshima, J. Mimuro, J. W. Weisel, A. Nagita, and M. Matsuda
End-linked homodimers in fibrinogen Osaka VI with a Bbeta -chain extension lead to fragile clot structure
Blood, December 1, 2000; 96(12): 3779 - 3785.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1999 by American Society of Hematology         Online ISSN: 1528-0020